Recent epidemiological and animal studies have suggested that excess intake of phosphate (Pi) is a risk factor for the progression of chronic kidney disease and its cardiovascular complications. However, little is known about the impact of dietary high Pi intake on the development of metabolic disorders such as obesity and type 2 diabetes. In this study, we investigated the effects of dietary Pi on glucose and lipid metabolism in healthy rats. Male 8-wk-old Sprague-Dawley rats were divided into three groups and given experimental diets containing varying amounts of Pi, i.e., 0.2 [low Pi (LP)], 0.6 [control Pi (CP)], and 1.2% [high Pi (HP)]. After 4 wk, the HP group showed lower visceral fat accumulation compared with other groups, accompanied by a low respiratory exchange ratio (V CO2/V O2) without alteration of locomotive activity. The HP group had lower levels of plasma insulin and nonesterified fatty acids. In addition, the HP group also showed suppressed expression of hepatic lipogenic genes, including sterol regulatory element-binding protein-1c, fatty acid synthase, and acetyl-CoA carboxylase, whereas there was no difference in hepatic fat oxidation among the groups. On the other hand, uncoupling protein (UCP) 1 and peroxisome proliferator-activated receptor-␥ coactivator-1␣ (PGC-1␣) expression were significantly increased in the brown adipose tissue (BAT) of the HP group. Our data demonstrated that a high-Pi diet can negatively regulate lipid synthesis in the liver and increase mRNA expression related to lipid oxidation and UCP1 in BAT, thereby preventing visceral fat accumulation. Thus, dietary P i is a novel metabolic regulator. dietary phosphate; energy metabolism; brown adipose tissue; visceral fat OBESITY CONTINUES TO BE A MAJOR PUBLIC HEALTH PROBLEM worldwide. Overnutrition and an increased consumption of fast foods are primary factors contributing to this problem. Fast foods or processed foods have high energy density and also frequently contain a large amount of P i as a food additive. Recent epidemiological studies have suggested that a high dietary P i intake can be associated with increased cardiovascular risk and other metabolic disorders.
OBESITY CONTINUES TO BE A MAJOR PUBLIC HEALTH PROBLEM worldwide. Overnutrition and an increased consumption of fast foods are primary factors contributing to this problem. Fast foods or processed foods have high energy density and also frequently contain a large amount of P i as a food additive. Recent epidemiological studies have suggested that a high dietary P i intake can be associated with increased cardiovascular risk and other metabolic disorders.
P i is an essential nutrient that significantly affects skeletal formation, energy metabolism, and intracellular signaling (43, 45) . P i homeostasis is regulated by the absorption of P i in the intestine, bone formation/resorption, and reabsorption of P i in the kidney. The kidney is particularly important in the regulation of P i homeostasis (36, 45) . Most P i -regulating factors, such as high/low P i intake, 1,25-dihydroxyvitamin D [1, 25(OH) 2 D], parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF23), can regulate P i reabsorption in the kidney to maintain the P i homeostasis (6, 36, 43) .
Recent epidemiological and animal studies have suggested that an excessive intake of P i is a risk factor for the progression of chronic kidney disease and the occurrence of cardiovascular complications (8, 45) . Excess P i has been independently associated with cardiovascular morbidity and mortality (1, 7) . On the other hand, metabolic syndrome represents an important cluster of risk factors for the development of cardiovascular disease (32, 48) , and it was proposed recently that disturbances in P i metabolism may be a key feature of metabolic syndrome, since both too high and too low serum P i levels have been correlated with cardiovascular risk factors and elements of metabolic syndrome (19, 23, 40) . It may be important to maintain an appropriate serum level of P i for the prevention of cardiac disease and metabolic syndrome. In addition, Ellam et al. (14) also demonstrated that a high-P i diet accelerated atherogenesis in apolipoprotein E knockout mice, whereas low dietary P i intake induced insulin resistance, adiposity, and hepatic steatosis. Our recent studies have also shown that dietary P i restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice (46) . However, the mechanisms by which an excessive amount of dietary P i could influence glucose and lipid metabolism have not been clarified. Thus, the aim of this study was to investigate the effects of dietary P i on glucose and lipid metabolism in healthy rats. We demonstrated that high P i intake suppressed body weight gain as a result of decreased hepatic lipogenesis and increased fat oxidation and UCP1 in BAT, which is indicative of augmented BAT activation.
MATERIALS AND METHODS
Animals and diets. Seven-week-old male Sprague-Dawley (SD) rats were purchased from SLC (Shizuoka, Japan) and were housed in individual cages in an animal room maintained under standard conditions with 12 h light-dark cycle and temperature (22 Ϯ 22°C) and provided with ultrapure water. Animals were divided into three experimental groups based on body weight and fed either 0.2 [low P i (LP)], 0.6 control Pi (CP), or 1.2% [high Pi (HP)] Pi diet, respectively, by a pair-feeding procedure for 4 or 14 wk. The composition of each diet is shown in Table 1 . The body weights of the rats were checked weekly during the experimental period, and their amount of daily food intake was recorded.
All rats were fasted overnight (12-14 h) prior to euthanization under anesthesia. Blood was collected into tubes containing heparin, and then plasma was separated by centrifugation at 2,000 g for 4 min and stored at Ϫ30°C until further analysis. The liver, kidney, muscle, brown adipose tissue, and epididymal fat samples were washed in 0.9% NaCl and immediately snap-frozen in liquid nitrogen and stored at Ϫ80°C. All animal studies were carried out in accordance with established guidelines for the care and handling of laboratory animals and were approved by the Animal Care and Use Committee of Tokushima University.
Oral glucose tolerance test. Oral glucose tolerance tests were performed after 3 wk of dietary intervention. The rats were fasted for 12 h before testing. Subsequently, a standard dose of glucose (2 g/kg body wt) was administered via gavage, and blood glucose levels were determined with a glucometer (Accu-Check) at 0, 15, 30, 60, 90, and 120 min after gavage in blood from the tail vein. Serum insulin levels were determined by an ultrasensitive rat enzyme kit (Morinaga). The homeostasis model assessment of insulin resistance (HOMA-IR) scores were calculated using fasting glucose and fasting insulin concentrations obtained from rats after 12-14 h of fasting and using the following formula: fasting blood glucose (mg/dl) ϫ fasting insulin (ng/ml)/405. O 2 consumption, respiratory quotient, and locomotive activity. O2 consumption and CO 2 production were measured continuously over 3 days using an Oxymax apparatus (Columbus Instruments, Columbus, OH). Animals were housed individually in sealed chambers with free access to food and drinking water. Each cage was monitored for both O2 consumption and CO2 production at 10-min intervals. Oxygen consumption and CO 2 were expressed as liters of O2 or CO2·kg body wt Ϫ1 ·h Ϫ1 . Locomotive activity was measured by using an infraredbased locomotive activity measurement device (ACTIMO; Bioresearch Center, Tokyo, Japan).
Real-time PCR. Total RNA was isolated from 100 mg of liver tissue using RNAiso Plus reagent (Takara). The brown part of the interscapular fat or epididymal fat was dissected. Total RNA was isolated from brown adipose tissue and epididymal fat using an RNeasy lipid tissue mini kit (Qiagen) according to the manufacturer's instructions. The cDNA was synthesized from 2.5 g of RNA using a reverse transcriptase kit (Invitrogen, Carlsbad, CA) with an oligo-dT primer. After cDNA synthesis, quantitative real-time PCR was performed in 20 l of SYBR Green PCR master mix using a real time PCR system (Applied Biosystems, Carlsbad, CA). The amplification programs were set as follows: initial denaturation at 95°C for 10 min, followed by 50 cycles of 95°C for 10 s, 60°C for 15 s, and 72°C for 15 s. The PCR products were checked by melting-curve analysis and 2% agarose gel electrophoresis. All sample mRNA levels were normalized to values for ␤-actin mRNA amplification, and the relative levels of gene expression were calculated by using the comparative C T method. The primer sequences used for real-time PCR analysis are shown in Table 2 .
Hepatic lipid contents. Hepatic lipids were extracted from 1.0 g of liver with chloroform-methanol (2:1, vol/vol), according to the method of Folch et al. (17) . Hepatic triglyceride (TG) and total cholesterol (T-Cho) concentrations were analyzed using the same protocol as that described for plasma triglyceride analysis. The TG and T-Cho contents were normalized by tissue weight.
Histology. The brown part of the interscapular fat was dissected and rinsed in phosphate-buffered saline (PBS) and then fixed in 4% buffered formalin. After an overnight wash, specimens were dehydrated in graded ethanol, cleared in xylene, and paraffin embedded, preserving their anatomic orientation. Sections (4 -5 m in thickness) were cut from paraffin blocks using a microtome, mounted on polylysine-coated slides, and stored at room temperature. For histochemical analysis, 2-to 5-m-thick paraffin sections were cut, deparaffinized, and stained with haematoxylin-eosin.
Biochemical analysis. Plasma P i, calcium, creatinine, and blood urea nitrogen (BUN) levels were measured using phospha-C, calcium-E, creatinine, and BUN test kits (Wako, Osaka, Japan), respectively. The concentration of PTH in plasma was measured by a Rat Intact PTH ELISA kit (Immutopics, San Clemente, CA), and plasma FGF23 was measured by an FGF23 ELISA kit (Kainos Laboratories, Tokyo, Japan). The concentration of leptin in plasma was determined using an ELISA kit (Morinaga), and that of adiponectin was determined using an ELISA kit (R & D Systems). The plasma 1,25(OH)2D concentration was analyzed by SRL (Tachikawa). The T-cho, TG, and 
ACC, acetyl-CoA carboxylase; FAS, fatty acid synthase; SREBP-1c, sterol regulatory element-binding protein-1c; PGC-1␣, peroxisome proliferator-activated receptor (PPAR)-␥ coactivator-1␣; CPT-1, carnitine palmitoyltransferase 1; UCP1 and -2, uncoupling protein 1 and 2, respectively; HSL, hormone-sensitive lipase; ChREBP, carbohyrate response element-binding protein; ACO, acyl-CoA oxidase.
nonesterified fatty acids (NEFA) concentrations were determined using specific assay kits (Wako, Osaka, Japan).
PET/CT protocol. Male SD rats aged 8 wk were used in this experiment. The rats were divided into three groups and fed the experimental diets for 4 wk. PET/CT imaging was performed in the P i diet treatment group before the experimental diet was started as a baseline (pre) and 4 wk after. [ 18 F]fludeoxyglucose ([ 18 F]FDG) PET/CT data were acquired using a Siemens Inveon small-animal PET/CT scanner (Siemens Healthcare, Knoxville, TN). All rats were fasted for 12-15 h, and then body weights and blood glucose levels were measured. Before PET/CT analysis, rats were anaesthetized using inhalant isoflurane (2%) throughout all imaging sessions. The rats were placed in a prone position on the bed of the PET/CT scanner, and a respiration pad was placed under their abdomen. Before the PET scan, rats had a CT scan for attenuation correction and anatomic delineation of PET images. [ 18 F]FDG (average radioactivity 13.0 MBq/rat) was administrated through the tail vein just after the start of PET data acquisition. PET data were acquired for 90 min, and data were reconstructed as 128 ϫ 128 ϫ 159 matrices with a transaxial pixel size of 0.776 mm.
Image analysis. [ 18 F]FDG uptake in the BAT was quantified using the image analysis software Inveon Research Workplace (Siemens Medical Solutions, Malvern, PA). The magnitude of BAT [
18 F]FDG activation was expressed as a standard uptake value (SUV), which was defined as the average [ 18 F]FDG activity in each volume of interest (VOI) divided by the injected dose (MBq) times the body weight of rats (g) (5). VOIs were selected based on PET images for interscapular BAT and CT images for interscapular white adipose tissue (WAT), similar to previously described methods (42) . After the VOIs were visually delineated, Hounsfield unit (HU) levels were thresholded to maximize the difference between BAT and WAT. The kinetic modeling was performed similarly to previously described methods (34) . The kinetic rate constants k 1, k2, and k3 were estimated. The [
18 F]FDG rate constants k1 and k2 are mediated by glucose transporters across cytomembranes, and k3 represents phosphorylation by hexokinase (35) . The FDG influx constant (ki) was computed as ki ϭ k1 ϫ k3/(k2 ϩ k3).
Cell culture and differentiation. HB2 cells (kindly provided by Prof. Masayuki Saito) were isolated from BAT of p53 knockout mice and were differentiated into mature brown adipocytes, as described previously (24) . In short, HB2 cells were seeded on collagen-coated dish and cultured in high-glucose medium (Sigma-Aldrich, Tokyo, Japan) supplemented with 10% fetal bovine serum (Invitrogen) and 1% penicillin-streptomycin. The medium was changed every 2 days until confluence. Then, 0.5 mM 3-isobutyl-1-methylxanthine and 1 M dexamethasone were added to induce differentiation. Two days after induction, the medium was changed to differentiation medium with 10 g/ml insulin and 50 nM triiodothyronine (T 3). For Pi stimulation experiments, we prepared sodium phosphate buffer (0.1 M Na 2HPO4/NaH2PO4, pH 7.4) and added in differentiation medium to produce final P i concentrations of 0.9, 2, and 3 mM. P i treatment started on day 0 of differentiation, as indicated in the figure legends. For PTH [human parathyroid hormone (1-34 fragment), Sigma-Aldrich, Japan] and FGF23 (recombinant human FGF23; R & D Systems), stimulation experiments were also started on day 0 of differentiation, as described in the figure legends.
Data analysis. Values are expressed as means Ϯ SE. Data were analyzed for differences between groups by Tukey-Kramer post hoc multiple comparisons test of one-way ANOVA. All data analysis was performed using GraphPad Prism 5 software (Graphpad Software, San Diego, CA). P Ͻ 0.05 was considered to indicate statistical significance. Fig. 1 . Body weight changes and food intake, visceral fat mass, and adipocyte hormones. A and B: body weight changes (A) and food intake (B) during dietary intervention. Body weight was measured every day during the experiment, and food intake was measured under the pair-feeding conditions during the light period every other day, and here the weekly average values are presented (n ϭ 6 for each group). C and D: body weight (C) and visceral fat mass (D) at 4 wk after the experimental diet period was started. Adipose tissues were measured as epididymal (eWAT), mesenteric (mWAT), and retroperitoneal white adipose tissue (rpWAT) depots. E and F: fasting plasma leptin (E) and fasting plasma adiponectin (F) levels in rats at 4 wk after the experimental diet period was started. Data are presented as means Ϯ SE (n ϭ 6). *P Ͻ 0.05; **P Ͻ 0.01. LP, low Pi; CP, control Pi; HP, high Pi.
RESULTS
Body weight change and visceral fat mass. Rats fed the HP diet showed significantly attenuated weight gain at 8 wk after the start of feeding (Fig. 1A) despite there being no differences in total food intake among the three diet groups throughout the experimental period (Fig. 1B) . In addition, when the rats were fed with the HP diet for 14 wk, the liver TG content was significantly lowered compared with the LP diet group (LP: 4.22 Ϯ 0.79 mg/g; CP: 2.57 Ϯ 0.51 mg/g; HP: 1.36 Ϯ 0.35 mg/g; P Ͻ 0.05, LP vs. HP, n ϭ 4 -6). These data indicate that dietary P i may affect energy metabolism in rats. To investigate the cause of reduced body weight gain in the HP group, we examined body weight and energy metabolism in that group at 4 wk after the start of feeding. At 4 wk, we did not find any significant differences in body weight (Fig. 1C) or the weights of liver, muscle, or other organs among groups (Fig. 2) . However, HP group rats exhibited the lowest amount of visceral fat accumulation (Fig. 1D) . Consistent with the decrease in the fat accumulation, HP group rats showed a marked decrease in their plasma leptin level compared with that of LP group rats (Fig. 1E ), whereas the plasma adiponectin level showed no significant differences among groups (Fig. 1F) .
Respiratory quotient and oxygen consumption. To elucidate the cause of the reduced body weight gain in the HP group, we measured the whole body metabolic rate by indirect calorimetry. Although there were no significant differences in oxygen consumption (V O 2 ) or carbon dioxide production (V CO 2 ) rates among the three groups (Fig. 3, A and B) , the respiratory quotient (RQ) (Fig. 3C) , which reflects carbohydrate and fat oxidation, was significantly decreased in the HP group during the dark phases compared with the CP group and was slightly decreased during the light phases (Fig. 3D) . Plasma free T 3 and free thyroxine 4, which can affect the basal energy expenditure (44), were also not different among the diet groups (Table 3 ). In addition, we investigated whether locomotive activity in the HP diet group was increased or not. As shown in Fig. 3E , there were no significant changes in locomotive activity between the CP and the HP diet groups. Taken together, these results indicate that the decreased body weight of HP group rats was at least in part due to the preferential consumption of fat for energy production.
Plasma marker and lipid profile. There were no significant differences in plasma P i and calcium levels among the groups (Table 4 ). However, the plasma level of PTH was significantly higher in the HP group than in the LP and CP groups, and another phosphaturic hormone, FGF23, showed a trend toward being increased in the HP group compared with the LP and CP groups. Urinary P i excretion in the HP group rats was significantly higher than that of the LP and CP groups. Interestingly, the plasma level of active vitamin D was significantly higher in Fig. 2 . Organ weight after 4 wk of the experimental diets being fed. At euthanization the organs were harvested and washed in saline, and then organ weight was measured after the saline was removed. BAT, brown adipose tissue.
the HP group than in the LP group. It was well known that PTH enhances 1,25(OH) 2 D synthesis as well as calcium reabsorption and P i excretion in the kidney (26) . The increased 1,25(OH) 2 D levels in the plasma may reflect the sixfold increase in the plasma PTH level in HP group rats (Table 4) . On the other hand, the fasting plasma TG, T-Cho levels, and hepatic lipid contents were unchanged, whereas the fasting plasma NEFA levels were significantly decreased in the HP group compared with those of the LP and CP groups ( Table 3) .
Effect of dietary P i on glucose tolerance and insulin tolerance in rats.
To address the effects of dietary P i on glucose metabolism in more detail, we also performed an oral glucose tolerance test (OGTT) in these rats after 3 wk of diet intervention. As shown in Fig. 4 , there were no significant differences in blood glucose levels among all experimental groups, whereas there was a slight increase in the blood insulin level of LP group rats compared with that of HP group rats. Plasma insulin levels showed peak values in all groups at 15 min after glucose administration (Fig. 4B) . Additionally, fasting insulin levels were significantly greater in LP group rats than in HP group rats, but there was no difference in fasting blood glucose levels among the groups (Fig. 4, C and D) . To evaluate the degree of insulin resistance, we performed the HOMA-IR and insulin tolerance test. HP group rats had a significantly lower average HOMA-IR score than LP group rats (Fig. 4E) . Consistent with OGTT results, insulin tolerance test also showed a slightly higher level of glucose in the LP group compared with CP and the HP group (Fig. 4F) . These data indicate that increased body fat accumulation in the LP group caused the impaired glucose tolerance and insulin sensitivity.
Effects of dietary P i on gene expression in the liver and white adipose tissue. The body weight, fat mass, and RQ data suggest that HP diet-fed rats may have had increased fatty acid oxidation, resulting in enhanced energy expenditure and reduced body weight gain. To further explore the responsible tissue, we examined the expression of genes involved in lipogenesis and lipolysis in liver and WAT. Animals fed the HP diet showed a significantly decreased hepatic expression of acetyl-CoA carboxylase (ACC) mRNA (Fig. 5A) , which is the All data are presented as means Ϯ SE. NEFA, nonesterified fatty acids; T3, triiodothyronine; T4, thyroxine 4. Blood and urine sampling was performed at euthanization under fasting conditions at 4 wk after the experimental diet period was started. Values with superscripts of a common letter differ significantly (P Ͻ 0.05; n ϭ 6 for each group). Fig. 3 . Effect of dietary Pi on respiratory quotient (RQ) and locomotive activity. A-C: oxygen consumption (V O2) and CO2 production (V CO2) and RQ (V O2/ V CO2) in rats fed diets containing different amounts of Pi for 3 wk (n ϭ 3-4 for each group). Values were collected over a 24-h period. D: average value of RQ data in the dark period (8 PM to 8 AM) and the light period (8 AM to 8 PM) were calculated and subjected to the statistical analysis. E: measured locomotive activity in CP and HP diet group rats (n ϭ 6). Time indicates clock time; 8 AM to 8 PM was the light phase, and 8 PM to 8 AM was the dark phase. Count means average no. across the infrared sensor per hour. Data are presented as means Ϯ SE (n ϭ 6). *P Ͻ 0.05. rate-limiting enzyme for fatty acid synthesis (18) . Sterol regulatory element-binding protein-1c (SREBP-1c) and fatty acid synthase (FAS) mRNA levels also tended to be lower in HP group rats than in LP group rats, but without statistical significance (Fig. 5, B and C) . On the contrary, the mRNA expression of PGC-1␣, which regulates genes involved in lipid oxidation and energy homeostasis (21), was slightly increased in HP group rats, but no significant differences in PGC-1␣ expression were identified among groups (Fig. 5D ). Carnitine palmitoyl transferase 1 and UCP2 mRNA levels in the liver were also not changed (Fig. 6) . On the other hand, the lowered plasma NEFA level in HP group rats (Table 3) suggests that fatty acid utilization was increased in WAT of this group. Unexpectedly, the mRNA level of hormone-sensitive lipase, which is a key enzyme for fatty acid mobilization (22) in WAT, was not different among the groups (Fig. 5G) . The expression levels of the lipogenesis-related genes we investigated, such as ACC (Fig. 5E ) and SREBP-1c (Fig. 5F) , were also not different among groups in WAT, and the expression levels of PGC-1␣ also did not differ among groups in WAT (Fig. 5H ). These observations indicate that repressed fat accumulation in HP group rats may have been a result of reduced lipogenesis in the liver, but the results do not indicate increased fat oxidation in liver or WAT.
Effect of dietary P i on gene expression in brown adipose tissue. Next, we analyzed the BAT, which contributes significantly to the control of body temperature and energy expenditure (10) . BAT weight was reduced in HP group rats compared with that of LP group (Fig. 2) . Expression of FAS mRNA was significantly lower in HP group rats than in LP group rats (Fig. 7A ), but there was no significant difference in All data are presented as means Ϯ SE. BUN, blood urea nitrogen; PTH, parathyroid hormone; 1,25(OH)2D, 1,25-dihydroxyvitamin D; FGF23, fibroblast growth factor 23. Blood and urine sampling were performed at euthanization under fasting conditions during a 4-wk period. Values marked with superscripts of a common letter differ significantly (P Ͻ 0.05; n ϭ 6 for each group). Fig. 4 . Effect of dietary Pi on oral glucose and insulin tolerance. A and B: after being fasted for 14 -16 h, the rats were given an oral dose of 2 g/kg body wt. Blood samples were taken at 0, 15, 30, 60, 90, and 120 min after glucose administration. Blood glucose (A) and insulin (B) levels measured after the feeding of diets containing different amounts of Pi for 3 wk (n ϭ 5 for each group). C-E: concentrations of fasting glucose (C) and insulin (D) and homeostasis model assessment of insulin resistance (HOMA-IR) score. F: insulin tolerance test was performed at 3 wk. Insulin (0.75 U/kg BW) was administrated intreparitoneally to the unanesthetized rats. Data are presented as means Ϯ SE (n ϭ 6). *P Ͻ 0.05.
SREBP-1c mRNA expression in BAT (Fig. 7B) . Surprisingly, expression of UCP1 mRNA, which encodes a BAT-specific thermogenic protein, was dramatically increased in HP group rats compared with that in LP and CP group rats (Fig. 7C) . PGC-1␣ mRNA expression in the BAT of HP group rats was also higher than that of LP and CP group rats (Fig. 7D) . This finding was consistent with a low RQ level in HP group rats. These results suggest that upregulation of UCP1 and PGC-1␣ expression in BAT must be related to the decreased fat accumulation and increased BAT activation in the HP group. (Fig. 8A) . Quantitative analysis of the [
18 F]FDG SUV of BAT also showed no significant difference among the groups (Fig. 8, B and C) . Baba et al. (3) reported previously that the CT HU value of BAT was increased in activated conditions in both animals and patients. The CT HU value of BAT was calculated manually by linear interpolation of water CT density (assuming CT HU ϭ 0) using image analysis software (Fig. 8, D and E) . The CT HU value of the BAT of HP group rats was decreased compared with that of the LP group. The change in the CT HU value was specific to BAT and related to the physiological alterations in this tissue. Our histological analysis of BAT revealed that the lipid content of BAT was decreased in the HP group (Fig. 8F) , indicating that the changes in the CT HU value may have reflected alterations in BAT volume. Because we did not find any differences in FDG uptake in BAT among groups, we performed further examinations using kinetic modeling (Fig. 9) . Kinetic modeling allowed quantification of the kinetic parameters k 1 , k 2 , k 3 , and k i in BAT. No significant differences were observed among groups in the averages of the FDG transport parameters k 1 and k 2 on the 4th wk of the experimental diet period (Fig. 9, A and  B) . Hexokinase activity (k 3 ) and the BAT net influx rate constant (k i ) for glucose were significantly smaller in the HP group than in the other groups (Fig. 9, C and D) , showing that these parameters can be altered depending on the amount of P i content in the diet. The kinetic data also indicated a significant decrease in FDG uptake in the HP group when compared with the other groups on the 4th wk of the experimental diet period.
These data suggested that a HP diet may be implicated in inhibiting glucose uptake in BAT.
Effect of P i stimulation on UCP1 expression in brown adipocytes. To gain further understanding of the mechanisms involved in dietary high-P i -induced UCP1 expression in BAT, we investigated the effects of P i and P i -regulating hormones on the expression of UCP1 mRNA in HB2 cells.First, we examined whether elevation of extracellular P i concentration could induce the expression of UCP1 mRNA in HB2 cells. As shown in Fig. 10A , the increase in P i concentration did not affect the mRNA expression levels of UCP1. We also tested the effect of PTH on the expression of UCP1 mRNA in HB2 cells. Adipose tissue can express PTH receptor (27) . In addition, PTH receptor is a G protein-coupled receptor that activates the cyclic AMP-dependent protein kinase pathway (47). So we hypothesized that high plasma levels of PTH in the HP group can induce the PKA signaling pathway, thereby promoting UCP1 expression. As shown in Fig. 10B , however, PTH did not affect the expression of the mRNA. Finally, we also examined the effect of FGF23, which is an important phosphaturic factor, on the expression of UCP1 mRNA in HB2 cells. As also shown in Fig. 10C is that FGF23 did not affect the expression of mRNA in HB2 cells (Fig. 10C) . These data indicate that elevated serum P i concentration and the P i -regulating hormones PTH and FGF23 did not directly affect the BAT activity in the HP group.
DISCUSSION
In the present study, we investigated the effects of dietary P i on glucose and lipid metabolism. The HP diet group showed a gradual and significant suppression of body weight gain until the 14th wk of the experimental diet period, although food intake was similar to that in other diet groups. A slight suppression of body weight gain by the HP diet was observed on the 4th wk. We hypothesized that a metabolic change had arisen on the 4th wk in the HP diet-fed rats. We found that ingestion of the HP diet for 4 wk reduced visceral fat mass but did not result in differences in the weights of liver, muscle, or other organs. We demonstrated that rats fed the HP diet showed decreased visceral fat mass and altered mRNA expression levels of lipogenesis-related genes such as ACC, FAS, and SREBP-1c in the liver. Furthermore, low RQ value in the HP group may be involved in the low fat accumulation. On the other hand, fat accumulation and impaired glucose tolerance/ insulin sensitivity was observed in the LP group.
The significant reductions in visceral fat accumulation found in HP group rats may be due to enhanced basal metabolism. Our data indicated that HP diet intake led to a preferential utilization of fat for energy production, because we demonstrated lowered levels of the respiratory quotient (V CO 2 /V O 2 ) in the HP group compared with the CP diet group without changes in locomotive activity. The suppressed fat mass could also be due to the reduced expression of hepatic lipogenic genes such as SREBP-1c, FAS, and ACC, whereas the expression levels of fat oxidation-related genes were not changed. Decreased fasting NEFA levels in the HP group rats suggested that most of the released NEFA were utilized for ␤-oxidation in the liver, BAT, or skeletal and cardiac muscles, although we did not directly evaluate lipolysis or ␤-oxidation in the muscle. Our data indicate at least in part that increased fat oxidation in BAT was primarily responsible for the decrease in visceral fat accumulation observed in HP diet-fed rats.
Body fat accumulation was regulated by various hormones such as insulin, leptin, and adiponectin. Leptin is a key regulator for the regulation of body mass and is produced almost exclusively by adipose tissue (13, 25) . Serum leptin levels have been reported to show a positive correlation with adiposity. In our study, the decreased leptin level in the HP group may reflect the decreased fat mass. We also observed a low plasma level of insulin in the HP group compared with the LP group but not the CP group; this may contribute to decreased visceral fat mass, since insulin increases glucose uptake in muscle and fat and inhibits lipolysis (41) . However, this study did not evaluate insulin signaling, and so further investigation will be required to determine the relative contributions of the altered plasma levels of leptin and insulin resulting from feeding with the HP diet in the decreased fat accumulation. Fasting plasma insulin level, HOMA-IR, and insulin tolerance test demonstrated that LP diet was involved in the insulin-resistant state, which was probably due to fat accumulation. We did not observe any significant difference between HP diet and CP diet groups, although low fat accumulation and body weight gain were observed. Greater dietary P i intake in humans can increase the circulating levels of PTH and FGF23 (2, 51). These hormones reduce P i concentration mainly by enhancing its renal excretion. It has been proposed that insulin sensitivity and HOMA-IR correlate inversely with plasma PTH (11) and FGF23 (49) in obese adults, suggesting that increased PTH and FGF23 levels may be associated with metabolic disorders. The more detailed mechanism of the effects of HP diet on glucose and lipid metabolisms must be investigated in a future study.
Furthermore, high dietary P i intake was associated with increased left ventricular mass (50) . Although the detailed mechanism has not been clarified, elevated FGF23 resulting from intake of a diet with a high P i content may lead to increased left ventricular mass. Faul et al. (15) demonstrated that FGF23 can influence left ventricular hypertrophy. An increase in left ventricular mass is also related to cardiovascular complications such as arrhythmia and heart failure. Interestingly, studies in human and animal models have suggested that insulin resistance and fat oxidation are improved in failed hearts (12, 37) . Although energy metabolism was increased by cardiac hypertrophy, there were no significant changes in heart mass in our HP diet-fed rats. Additionally, our experiment demonstrated that neither PTH nor FGF23 increased the expression of UCP1 mRNA in HB2 cells, indicating that the induced UCP1 mRNA expression by ingestion of high dietary P i may be due to other mechanisms, including the sympathetic nervous system.
BAT is known to play an important role in fat oxidation by regulating thermogenesis (10, 28) , which is mediated by its characteristic protein UCP1 (33) . The importance of UCP1, the major uncoupling protein isoform expressed in BAT, has been understood in the development of obesity in UCP1-ablated mice (16) . Furthermore, upregulated UCP1 expression was reported to result in increased thermogenesis and energy expenditure, which helps to protect from obesity and fat accumulation (29) . This upregulation of UCP1 can be mediated by the transcriptional factor PGC-1␣ (21, 30) . In our study, a consistently high level of PGC-1␣ mRNA expression was observed in HP group rats, suggesting that thermogenesis was increased in the BAT of these animals. However, it remains unclear how a high-P i diet can affect UCP1 expression in BAT. NEFAs in serum are normally rapidly taken up by BAT, and HP diet intake should stimulate UCP1 expression to increase thermogenesis and energy expenditure in BAT, as described in another study (33) .
Measuring the metabolic activity of BAT is important for the development of novel strategies for the evaluation of energy expenditure. Glucose uptake by BAT is increased when it becomes metabolically active (38) . Unexpectedly, dietary P i had no effect on FDG uptake in BAT. This finding was possibly because of the following reasons: 1) low plasma insulin level (as discussed above, low fasting plasma insulin level may explain low glucose uptake in BAT in HP diet group; however, the insulin level was significantly different between LP diet and HP diet groups but not CP diet and HP diet group); 2) ambient temperature (the influence of exposure to cold on BAT activity is potentially important for the interpretation of FDG PET/CT studies) (3); or 3) pharmacological stimulants (to active BAT at ambient temperatures, it was necessary to stimulate the noradrenergic receptors). These reasons may be implicated in the low FDG uptake in all groups. In this study, BAT did not receive any stimuli to activate glucose uptake. Although we did not observe FDG accumulation in our study, it was most likely activated because HP group rats exhibited higher body temperatures (HP vs. LP: 34.1 Ϯ 0.7 vs. 33.3 Ϯ 0.4°C). BAT takes up glucose for oxidation, and its utilization of glucose is increased under thermogenic conditions. Some studies have pointed out that glucose uptake in BAT may not always reflect its thermogenic activity, since glucose taken up by this tissue is used predominantly for lipogenesis (31) , and its uptake is dependent on intracellular TG content (9). Moreover, thermogenic activity is regulated mainly by the sympathetic nervous system, which innervates mostly BAT. The main fuel for this heat generation in BAT is fatty acids, which provide most of the energy for heat production (20) . In healthy men, BAT can significantly contribute to cold-induced thermogenesis and is fueled mostly by fatty acids (4, 39) . In here, the HP group showed inhibited hexokinase (HK) activities, as measured by decreases in the kinetic parameters k 3 and k i . As mentioned above, reduction of glucose uptake by inhibition of HK activity in the HP group may also increase fatty acids utilization in BAT, and this interpretation is supported by our histological analysis of BAT and kinetic analysis data; however, we did not examine NEFA uptake or fatty acid transport in BAT. Our data imply that a high-P i diet may suppress glucose uptake and increase fatty acid utilization in BAT of the rats.
Another unexpected result was that the LP group did not increase RQ value, although impaired glucose tolerance/insulin sensitivity and fat accumulation were observed as reported previously (14) . Increases in plasma leptin level and impairment of glucose tolerance/insulin sensitivity resulted from increased fat accumulation. Although fat accumulation increased in the LP group, the expressions of UCP1 and PGC-1␣ mRNA and RQ value in the LP group were not increased. Further investigation will be needed to clarify the effect of dietary P i restriction on glucose and lipid metabolism.
In conclusion, we demonstrated that administration of a high-P i diet decreased visceral fat mass via increased fat oxidation and suppressed fatty acid synthesis as well as increased UCP1 mRNA expression in BAT. The physiological importance of the effects of a high P i diet on energy metabolism should be clarified in a future study.
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